Glasgow-based pharmaceutical social intelligence company Talking Medicines is aiming for growth in 2021 with three senior appointments.
Tatiana Nantes joins in the newly-created role team as head of product, responsible for the delivery of social intelligence solutions for the pharmaceutical industry.
Meanwhile, Tom Lynch will become a senior engineer and Adrian Mursec has been hired as a front-end developer.
Lynch is a software engineer based in London with a background in consultancy and broad experience in data science, analytics and data engineering, having built and maintained big data pipelines in the cloud for clients in retail, energy and insurance sectors.
Mursec is a developer based in Manchester, with 15 years’ experience of has working with startups, agencies and large tech companies.
The latest hires follow a £1.1m fund raise led by Tern in November, which is being used to scale up Talking Medicine’s artificial intelligence-based data technology platform to track patient experience for the pharmaceutical industry.
Following the investment by Tern, Al Sisto joined the board as chairman.
Chief executive Jo Halliday said: “2021 is a huge year for Talking Medicines - having been in a deep R&D stage developing our AI offering, we are now in a great position to launch our platform to the pharma industry.
"Tatiana, Tom and Adrian will all provide invaluable expertise and experience as we embark on this next phase of growth with a view to securing Series A funding later this year.”
Don't miss the latest headlines with our twice-daily newsletter - sign up here for free.
